BioCardia, Inc.
BCDA
$2.10
-$0.17-7.49%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | -- | 3.00K | 55.00K | 13.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | -- | 3.00K | 55.00K | 13.00K |
| Cost of Revenue | -1.56M | 931.00K | 800.00K | 1.24M | 1.16M |
| Gross Profit | 1.56M | -931.00K | -797.00K | -1.19M | -1.14M |
| SG&A Expenses | 906.00K | 825.00K | 852.00K | 1.09M | 941.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.32M | 1.76M | 1.65M | 2.33M | 2.10M |
| Operating Income | -2.32M | -1.76M | -1.65M | -2.28M | -2.08M |
| Income Before Tax | -2.30M | -1.74M | -1.65M | -2.27M | -2.07M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.30M | -1.74M | -1.65M | -2.27M | -2.07M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.30M | -1.74M | -1.65M | -2.27M | -2.07M |
| EBIT | -2.32M | -1.76M | -1.65M | -2.28M | -2.08M |
| EBITDA | -2.31M | -1.74M | -1.63M | -2.26M | -2.06M |
| EPS Basic | -0.50 | -0.61 | -0.88 | -1.35 | -1.38 |
| Normalized Basic EPS | -0.31 | -0.38 | -0.55 | -0.85 | -0.86 |
| EPS Diluted | -1.00 | -0.61 | -0.88 | -1.35 | -1.38 |
| Normalized Diluted EPS | -0.31 | -0.38 | -0.55 | -0.85 | -0.86 |
| Average Basic Shares Outstanding | 4.59M | 2.83M | 1.88M | 1.68M | 1.50M |
| Average Diluted Shares Outstanding | 4.59M | 2.83M | 1.88M | 1.68M | 1.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
